From the ∗Washington University School of Medicine
†Division of Infectious Diseases, Department of Medicine
‡Divisions of Infectious Diseases and Public Health Sciences, Departments of Medicine and Surgery
§Division of Biostatistics
∥Department of Medicine/Siteman Cancer Center, Washington University in St Louis, School of Medicine
¶Department of Family and Community Medicine and Department of Health Outcomes Research, St Louis University School of Medicine, St Louis, MO.
Received July 26, 2021; accepted after revision September 23, 2021.
An earlier version of this article, with data models utilizing existing users of the study drugs instead of new users, was posted as a preprint. Preprint doi: https://doi.org/10.1101/2021.06.06.21258408
Reprints: Tahir Rahman, MD, Department of Psychiatry, Washington University in St Louis, 660 S Euclid Ave, Campus Box 8134, St Louis, MO 63110 (e-mail: [email protected]).
A podcast discussing this article is available online at the journal website.
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.psychopharmacology.com).